PTEN Hamartoma Tumor Syndrome clinical trials at UC Cancer
1 research study open to eligible people
Showing trials for
Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
open to eligible people ages 18 months and up
The purpose of this study is to determine cross-sectional and longitudinal medical, behavioral, and cognitive differences between PTEN ASD and other groups, as well as to identify cognitive, neural systems, and molecular biomarkers specific to PTEN ASD. In addition, this study will be creating and maintaining a biorepository and linked phenotypic database for PTEN ASD.